UK Biobank is a very large and detailed prospective study with over 500,000 participants aged 40 to 69 when recruited in 2006-2010. The study has collected and continues to collect extensive phenotypic and genotypic detail about its participants, including data from questionnaires, physical measures, sample assays, accelerometry, multimodal imaging, genome-wide genotyping and longitudinal follow-up for a wide range of health-related outcomes.
Scientific field(s): Biomedical
Data contained includes the following:
COVID-19 data (testing, vaccines etc)
Demographic and lifestyle (age, sex, education, smoking, diet etc)
Environment (air pollution, socioeconomic index etc)
Genetics and genomics (genotypes, WES, WGS)
Health records (ICD codes, GP data, cancer registry etc)
Imaging (DICOM/NIfTI, derived traits)
Omics (proteomics, metabolomics)
Physical and clinical measures (blood pressure, BMI, spirometry etc)
Method(s): Whole-genome sequencing, Exome sequencing, Sample collection, Imaging, Interviews, Physical measurements, Questionnaires, Record linkage
Samples are collected from participants (blood, saliva, urine), and physical measurements taken.
Information was collected about participants' health through interviews and online questionnaires.
Genetic data are obtained through WES/WGS sequencing, proteomic, metabolomic and epigenomic assays.
Imaging data are obtained through MRI and OCT imaging.
Data collection also includes linkage to NHS files as well as geospatial linkage and environmental modelling.
Associated ressources:
-
10.1371/journal.pmed.1001779: Sudlow, C. et al. UK Biobank: An Open Access Resource for Identifying the Causes of a Wide Range of Complex Diseases of Middle and Old Age. PLOS Med. 12, e1001779 (2015).
Catalogue record last updated: Feb. 20, 2026, midnight
| Data collectors |
UK Biobank University of Manchester |
| Data collection period |
2006-now |
| Is data still collected? |
Yes |
| Variable count/number |
ND |
| Sample size (of participants) |
500,000 |
| Geographic coverage (of participants) - Countries
|
United Kingdom of Great Britain and Northern Ireland |
| Geographic coverage (of participants) - Regions
|
Europe |
| Age range (of participants) |
40-69 |
| Age range (of participants) - Categories |
Adults |
| Family data? |
No
|
| Database host |
Amazon Web Services (AWS) |
| Hosting countries |
United States of America |
| Version (of the database) |
v20 |
| File format |
VCF BGEN CSV CRAM PLINK TSV TXT |
| Database size |
30+ PB |
| Data access |
Restricted Access |
| Data sharing policy |
Researchers who wish to access the data must first register on the Access Management System (AMS), which ensure requesters are appropriately employed and a bona fide researcher.
Once a researcher is registered, they need to submit an application to access the data. Each application is reviewed by the UK Biobank Access Team and the UK Biobank Scientific Team.
Once the application is approved (within a few weeks), the researcher must pay the Access Fees and the MTA (which is non negotiable).
Projects that used or are using UK Biobank data (11,000) are listed on UK Biobank's website. |
| Data downloadable? |
No |
| Data downloadable? (details) |
Analyses are run on a secure cloud platform. |
| Fees |
Yes |
| Fees (details) |
Tier 1: questionnaire and physical measurements; health outcome phenotypes; linked health data; web-based questionnaires. £3,000 (£1,000 per year extension).
Tier 2: Everything from Tier 1 plus: biochemical and haematological assays; other platform-based assays; measured and imputed genotypes; other enhancements. £6,000 (£2,000 per year extension).
Tier 3: everything from Tier 2 plus: imaging data; other large-scale assay data; whole genome sequence data; whole exome sequence data. £9,000 (£3,000 per year extension).
Additional institution fee- each additional institution added to an application: £1,000 for the first 3 years (£500 per year extension).
Lower income countries and student researchers: £500 for the first 3 years (£175 per year extension).
Fees are exclusive of VAT.
In addition to the access fee, researchers using the UK Biobank Research Analysis Platform (UKB-RAP) will incur costs related to their analysis. These include:
Compute resources, storage of data, data egress. |
| Usable for commercial purposes? |
Yes |
| Access for Pasteur scientists |
https://pasteurfr.sharepoint.com/:b:/s/VieScientifique/IQDQ338tr_aQQoQzufjqTGs6Aeb8fmsZTg9Jerj3RW3f2kA?e=fDP7y8
|